Waddell & Associates, LLC Viatris Inc Transaction History

Waddell & Associates, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	SELL	$9.59 - $11.35 $3,701 - $4,381	-386 Reduced 2.44%	15,461 $152,000
Q2 2023 Aug 07, 2023	BUY	$9.02 - $10.29 $142,939 - $163,065	15,847 New	15,847 $158,000
Q3 2022 Nov 02, 2022	SELL	$8.48 - $11.13 $5,707 - $7,490	-673 Reduced 3.52%	18,427 $157,000
Q2 2022 Jul 27, 2022	BUY	$9.95 - $12.27 $31,830 - $39,251	3,199 Added 20.12%	19,100 $200,000
Q1 2022 Apr 21, 2022	BUY	$9.81 - $15.4 $155,988 - $244,875	15,901 New	15,901 $173,000
Q4 2021 Feb 01, 2022	SELL	$12.09 - $14.68 $217,789 - $264,445	-18,014 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$13.25 - $15.13 $238,685 - $272,551	18,014 New	18,014 $244,000

1,103

931M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $14.2B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Waddell & Associates, LLC, based on Form 13F filings with the SEC.

Stay updated on Waddell & Associates, LLC with notifications on news.